Neurology Minute
In part two of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the OPTIMISTmain Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference:
info_outlineNeurology Minute
In part one of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the BRIDGE-TNK Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference:
info_outlineNeurology Minute
Dr. Elizabeth Coon and Dr. Peter Novak discuss how central sensitization plays a role in the autonomic symptoms-sings dichotomy and the importance of addressing both conditions for optimal treatment. Show references:
info_outlineNeurology Minute
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Jean Holowach-Thurston.
info_outlineNeurology Minute
In the second installment of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss clinical guidance for managing patients who may experience neurotoxicity from CAR T-cell, with a specific focus on seizure risk. Show reference:
info_outlineNeurology Minute
In the June episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss advocacy opportunities. Show reference:
info_outlineNeurology Minute
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss the incidence of acute symptomatic seizures during CAR T-cell therapy. Show reference:
info_outlineNeurology Minute
Dr. Halley Alexander and Dr. Serena Yin discuss the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of PNES. Show references:
info_outlineNeurology Minute
In the first episode of this new series, Dr. Andy Southerland discusses the June updates from the AAN's Capitol Hill Report (CHR). This month's CHR update includes a member story from Dr. José Posas. Stay updated with what’s happening on the hill by visiting . Learn how you can with AAN advocacy.
info_outlineNeurology Minute
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis. Show reference:
info_outlineDr. Jeff Lambe talks about progressive multiple sclerosis.
Show references:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract
https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967
https://jamanetwork.com/journals/jamaneurology/article-abstract/2809772
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988